PPD Buys BioDuro, Its Second Major China CRO Acquisition This Month
November 18, 2009 at 06:06 AM EST
PPD, Inc. is quickly building up its China-based CRO capability. The company announced it will acquire BioDuro LLC, a CRO based in Beijing whose 660 employees focus on drug discovery. The acquisition complements PPD’s purchase of Excel PharmaStudies earlier this month. Excel is a CRO that conducts Phase II through Phase IV clinical trials from its offices throughout China. PPD did not disclose financial details of either transaction. More details... Stock Symbol: (NSDQ: PPDI)